On January 7, 2022, the Board of Directors of Absci Corporation, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Joseph Sirosh to the Board effective that same date. Simultaneously with Dr. Sirosh's appointment, the size of the Board was fixed at seven directors and a third director position was added among the Class III directors. Dr. Sirosh will serve as a Class III director of the Company, to hold office until the Company's 2024 annual meeting of stockholders or until his earlier resignation, death, or removal.